Qui Som

Home > Qui Som
Dr. Xavier Valldeperas
Dr. Xavier Valldeperas

Dr. Xavier Valldeperas

Què he fet?

  1. Metge adjunt del servei d’Oftalmologia de l’Hospital Universitari Germans Trias (Badalona) 2005 a l’actualitat
  2. Professor Titular interí d’Oftalmologia de la Universitat Autònoma de Barcelona, Unitat Docent  Germans Trias 2010 a 2012
  3. Professor Associat d’Oftalmologia de la Universitat Autònoma de Barcelona, Unitat Docent  Germans Trias 2008-2010, 2013-actualitat
  4. Metge adjunt responsable de la cirurgia vitreoretiniana de l’Institut Oftalmològic Clinsafa  (Barcelona) 2006-2012
  5. Tutor de residents d’Oftalmologia de l’Hospital Universitari Germans Trias (Badalona) 2006-2012
  6. Vitreoretinal Fellowship al Royal Liverpool Hospital (Liverpool, UK) 2005
  7. Clinical Fellowship a l’Oxford Eye Hospital(Oxford, UK) 2004
  8. Doctorat en Medicina i Cirurgia per la Universitat Autònoma de Barcelona, amb qualificació  d’Excel•lent cum laude Desembre 2004
  9. Vitreoretinal Observership al Moorfields Eye Hospital(Londres, UK)  2003
  10. Vitreoretinal Observership al  Thomas Hospital (Londres, UK) 2003
  11. Metge Intern Resident d’Oftalmologia a l’Hospital Universitari Joan XXIII (Tarragona) 2000-2004
  12. Llicenciatura en Medicina i Cirurgia per la Universitat de Barcelona, a la unitat docent de  l’Hospital Clínic i Provincial de Barcelona i l’Hospital Universitari de Bellvitge 1993-1999

Dr. Xavier Valldeperas

A quines societats científiques pertanyo?

Dr. Xavier Valldeperas

Què he publicat en les revistes científiques?

  1. “Revisió de la prevenció i el tractament de la toxoplasmosi ocular”. Pardo A, Callizo J, Valldeperas X. Annals de la Societat Catalana d’Oftalmologia 2004
  2. “Resolution of cystoid macular oedema after retinal detachment repair: is intravitreal triamcinolone useful?” Valldeperas X, Romano M, Wong D. Eye. 2006 Nov;20(11):1321-2
  3. “Can the sequential use of conventional silicone oil and heavy oil be a strategy for the management of proliferative vitreoretinopathy?” Wong D, Cazabon J, Ali H, Kumar I, Valldeperas X, Groenewald C, Pearce I. Annals of the Singapore Academy of Medicine. 2006 Mar;35(3):181-4
  4. “Bilateral ischaemic maculopathy in a patient with AIDS”. Valldeperas X, Romano M. European Journal of Ophthalmology. 2006 Sep-Oct;16(5):761-3.
  5. “Is it worth reoperating on macular holes”. Valldeperas X, Wong D. Ophthalmology. 2008 Jan;115(1):158-63
  6. “Comparison of postoperative intraocular pressure in patients with Densiron-68 vs conventional silicone oil: a case-control study”. Wong D, Kumar I, Quah SA, Ali H, Valldeperas X. Eye. 2009 Jan;23(1):190-4
  7. “Abordaje transconjuntival más transcaruncular extendido. Amplia exposición de la pared medial orbitaria: una alternativa al abordaje coronal”. Rodriguez J, Galan R, Valldeperas X, Mateos M, Forteza G. Rev Esp Cir Oral Maxilofac. 2008;30(3):195-200
  8. Macular sensitivity changes for detection of chloroquine toxicity in asymptomatic patient”. Angi M, Romano V, Valldeperas X, Romano F, Romano MR. Int Ophthalmol. 2010 Apr;30(2):195-7
  9. “Bilateral keratectasia 34 years after corneal transplant”. Valldeperas X, Angi M, Romano V, Romano MR. Case Rep Ophthalmol. 2010 Jul 2;1(1):24-29
  10. “Tonic pupil and corneal anesthesia after vitrectomy and encircling band for retinal detachment in an ex-premature child”. Valldeperas X, Arango A, Blazquez A, Romano MR. Case Rep Ophthalmol. 2010 Sep 29;1(2):66-70
  11. “Inferior pseudophakic retinal detachment”. Romano M, Vinciguerra P, Valldeperas X, Romano V, Angi M, Furgiuele D, Costagliola C. Ophthalmology. 2010 Nov;117(11):2233.e3-4.
  12. “Sub-macular surgery: is still an option for age-related macular degeneration?” Romano MR, Valldeperas X, Vinciguerra P, Wong D. Curr Drug Targets. 2011 Feb 1;12(2):190-8
  13. “Intraocular pressure changes following the use of Silicona oil or Densiron-68 as endotamponade in pars plana vitrectomy”. Romano MR, Angi M, Romano V, Parmeggiani F, Campa C, Valldeperas X, Costagliola C. Clinical Ophthalmology. 2010 Nov 26;4:1391-1396
  14. “Twenty-three-gauge pars plana vitrectomy, Densiron-68 and 360º endolaser versus combined 20-gauge pars plana vitrectomy, scleral buckle and SF6 for pseudophakic retinal detachment with inferior breaks”. Romano MR, Angi M, Valldeperas X, Costagliola C, Vinciguerra P. Retina. 2011 Apr;31(4):686-91
  15. “Outer retinal layers”. Romano MR, Vinciguerra P, Radice P, Scialdone A, Valldeperas X, Romano V, Romano F, Costagliola C. Ophthalmology. 2011; 118(5):1006-1006.e2.
  16. “Use of Intravitreous bevacizumab for the treatment of choroidal neovascularization secondary to choroidal rupture”. Valldeperas X, Bonilla R, Romano MR, De la Cámara J. Arch Soc Esp Oftalmol. 2011 Nov;86(11):380-3
  17. “Primary 23-gauge sutureless vitrectomy for rhegmatogenous retinal detachment”. Romano MR, Das R, Groenwald C, Stappler T, Marticorena J, Valldeperas X, Wong D, Heimann H. Indian J Ophthalmol. 2012 Jan;60(1):29-33
  18. “Photodynamic therapy of symptomatic choroidal nevi”. Anselem L, Gündüz K, Adan A, Karslioglu MZ, Rey A, Sabater N, Valldeperas X. Middle East Afr J Ophthalmol. 2011 Oct;18(4):309-313(4).
  19. “Photodynamic therapy for symptomatic subretinal fluid related to choroidal nevus”. García-Arumi J, Amselem L, Gunduz K, Badal J, Adan A, Zapata MA, Valldeperas X, Huste F, Corcóstegui B. Retina. 2012. Feb 23
  20. “Heavy silicone oil – Densiron®- and supine position in the management of massive suprachoroidal hemorrhage”. Valldeperas X, Elizalde J, Romano MR, Wong D. Retinal Cases and Brief Reports. 2010 Accepted for publication.